ArticleMolecular therapy oncolytics2022

Combination of a STAT3 inhibitor with anti-PD-1 immunotherapy is an effective treatment regimen for a vemurafenib-resistant melanoma.

Tae Woo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.